Gelre Hospitals
- Address
- lock Available on a paid plan
Cardiovascular Disease and Heart Failure
At Gelre Hospitals in Zutphen, a major focus is on cardiovascular research, with studies addressing atherosclerotic cardiovascular disease, myocardial infarction, atrial fibrillation, and heart failure with reduced ejection fraction. These trials aim to test new treatments, improve prevention, and reduce the risk of serious heart-related events.
- Testing therapies to lower the risk of heart attack, stroke, and other major cardiovascular events
- Evaluating new approaches for heart failure after myocardial infarction
- Studying better prevention of thromboembolism and bleeding in patients with atrial fibrillation
The site’s Research Cardiologie department supports work that aims to improve long-term outcomes for patients with common and high-risk cardiovascular diseases.
Oncology and Hematologic Malignancies
The trial portfolio includes a strong emphasis on cancer research, especially lymphoma, breast cancer, lung cancer, esophageal cancer, prostate cancer, and multiple myeloma. Research at this hospital is focused on testing new treatment combinations, improving disease control, and extending survival in both solid tumors and blood cancers.
- Evaluating novel treatment strategies for diffuse large B-cell lymphoma, follicular lymphoma, and other non-Hodgkin lymphomas
- Studying new options for advanced breast cancer, including HER2-positive and hormone receptor-positive disease
- Assessing therapies for advanced non-small cell lung cancer and esophageal cancer
- Exploring personalized treatment for multiple myeloma and other advanced cancers
Much of this work aims to improve treatment effectiveness while also reducing toxicity and supporting more individualized cancer care.
Respiratory Diseases and Infectious Conditions
Clinical studies in respiratory medicine and infection-related disease cover COPD, asthma, bronchiectasis, idiopathic pulmonary fibrosis, pneumonia, influenza, and respiratory syncytial virus infections. The purpose is often to test better symptom control, reduce exacerbations, and improve recovery in patients with complex lung disease or serious infections.
- Testing treatments to reduce flare-ups in chronic obstructive pulmonary disease and severe asthma
- Studying new ways to manage bronchiectasis, idiopathic pulmonary fibrosis, and chronic cough
- Evaluating therapies for pneumonia, influenza, and acute respiratory distress syndrome
- Improving care for patients with difficult-to-treat respiratory infections
These studies reflect a broad interest in both long-term respiratory disease management and acute pulmonary illness.
Kidney Disease, Metabolic Disorders, and Cardiorenal Risk
Research also covers chronic kidney disease, end-stage kidney disease, obesity, overweight, severe hypertriglyceridemia, and related metabolic disorders. The main goal is to evaluate treatments that may protect kidney function, improve metabolic health, and lower the risk of cardiovascular complications.
- Assessing therapies for chronic kidney disease and end-stage kidney disease
- Studying treatments that may improve lipid disorders and metabolic risk
- Exploring options to reduce combined cardiac and renal events in high-risk patients
This area links kidney care with broader prevention of serious cardiovascular and metabolic complications.
Neurology, Stroke Prevention, and Ear Disorders
Several studies focus on neurological and vascular conditions such as ischemic stroke, transient ischemic attack, chronic subdural hematoma, and Menière's disease. The research is designed to improve prevention, reduce recurrence, and support better symptom control in patients with disabling neurological or balance-related disorders.
- Testing strategies to prevent recurrent stroke and systemic embolism
- Evaluating treatments for chronic subdural hematoma to reduce the need for surgery
- Studying symptom relief in Menière's disease and related vestibular complaints
These trials aim to improve both safety and daily functioning for patients affected by cerebrovascular and neurologic disease.
Musculoskeletal, Pain, and Reconstructive Care
Another important area includes musculoskeletal and pain-related research, with studies in chronic pancreatitis pain, postoperative pain, polymyalgia rheumatica, and joint prosthesis infection. The goal is to find better ways to relieve pain, reduce complications, and improve recovery after procedures or surgery.
- Evaluating pain control strategies after breast cancer surgery and in chronic pancreatitis
- Studying treatment approaches for polymyalgia rheumatica to improve disease management
- Comparing infection treatments for prosthetic joint infection
Work in this area supports more effective symptom relief and safer recovery across a range of musculoskeletal and postoperative conditions.
Women's Health, Fertility, and Urogenital Disorders
Clinical trials also address fertility, reproductive health, and urogenital disorders, including infertility, uterine fibroids, vulvar high-grade squamous intraepithelial lesion, and female urogenital complications. These studies aim to improve reproductive outcomes, prevent recurrence, and support better care for women with gynecologic conditions.
- Testing ways to improve live birth rates in fertility treatment
- Evaluating prevention of recurrence in vulvar HSIL
- Studying management options for uterine fibroids and other reproductive disorders
This research reflects a practical focus on both fertility support and the treatment of common gynecologic conditions.
Diagnostics, Anesthesia, and Perioperative Care
Some trials at this site concentrate on diagnostic procedures, sedation, and perioperative management. These studies are designed to improve patient comfort, recovery, and procedural safety in everyday hospital care.
- Comparing sedation options for upper gastrointestinal endoscopy
- Evaluating nerve block techniques for mastectomy surgery
- Studying ways to improve outcomes around surgical care and diagnostic procedures
Although smaller in scope than the cardiology and oncology programs, this work supports better hospital-based care and a smoother patient experience.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 20 therapeutic areas and 15 of 196 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 186 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 30 by active trials.
- 1Amsterdam UMC Stichting7active
lock +29 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amsterdam UMC Stichting11trials
lock +21 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gelre Hospitals
lock Showing 1 of 89 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b, Multicenter, Randomized, Double-blind, Parallel group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis | CSL Behring LLC | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 196 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rituximab | 5 | Unknown | 2023-01-26 | 2024-08-15 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
